Conflicts of Interest in Clinical Practice and Research
David Bourget (Western Ontario)
David Chalmers (ANU, NYU)
Rafael De Clercq
Jack Alan Reynolds
Learn more about PhilPapers
Oxford University Press (1996)
Our society has long sanctioned, at least tacitly, a degree of conflict of interest in medical practice and clinical research as an unavoidable consequence of the different interests of the physician or clinical investigator, the patient or clinical research subject, third party payers or research sponsors, the government, and society as a whole, to name a few. In the past, resolution of these conflicts has been left to the conscience of the individual physician or clinical investigator and to professional organizations. The public is no longer willing to allow health care providers to wholly govern their own conflicts of interest for several reasons. These include: new forms of health care financing and delivery that provide innovative and lucrative opportunities for physician or insurer enrichment at patient expense; the increased importance of commercial research support as peer-reviewed governmental research support has decreased; evidence that physicians and clinical investigators too frequently resolve conflicts of interest in their own favor; and a general societal mistrust of authority. This volume represents a multidisciplinary effort, drawing from philosophy, medicine, law, economics and public policy to identify and categorize conflicts of interest in medical practice and clinical research, and, where possible, to offer a mechanism for resolving them. Part I addresses conflicts of interest from a theoretical perspective, offering basic concepts and analytical frameworks. The second part discusses two topics prominent in current health care policy debates--self-referral and financial incentives to limit care. Part III examines conflicts of interest generated by pharmaceutical industry involvement in clinical practice and research. The final section deals with conflicts of interest in clinical research in several contexts, including institutional reviews boards, clinical trials, Cooperative Research and Development Agreements between government and private researchers, brokerage of research subjects by Contract Research Organizations, and cost-effectiveness studies.
|Keywords||Medical ethics Conflict of interests Conflict of Interest Ethics, Medical Referral and Consultation Health Maintenance Organizations Research|
|Categories||categorize this paper)|
|Buy the book||$3.52 used (94% off) $39.18 new (29% off) Amazon page|
|Call number||R724.C627 1996|
Setup an account with your affiliations in order to access resources via your University's proxy server
Configure custom proxy (use this if your affiliation does not provide a proxy)
|Through your library|
References found in this work BETA
No references found.
Citations of this work BETA
Lance K. Stell (2009). Drug Reps Off Campus! Promoting Professional Purity by Suppressing Commercial Speech. Journal of Law, Medicine and Ethics 37 (3):431-443.
Similar books and articles
Thomas H. Murray & Josephine Johnston (eds.) (2010). Trust and Integrity in Biomedical Research: The Case of Financial Conflicts of Interest. Johns Hopkins University Press.
Boleslav Lichterman (2002). Conflict or Harmony? Clinical Research and the Medical Press in Russia. Science and Engineering Ethics 8 (3):383-386.
Arvo Tikk (2002). Conflict of Interest in Medical Research in Estonia. Science and Engineering Ethics 8 (3):317-318.
Paul J. Friedman (1992). The Troublesome Semantics of Conflict of Interest. Ethics and Behavior 2 (4):245 – 251.
Delon Human (2002). Conflicts of Interest in Science and Medicine: The Physician's Perspective. Science and Engineering Ethics 8 (3):273-276.
Sarah Roberts-Cady (2010). Conflict of Interest in Industry-Sponsored Clinical Research. International Journal of Applied Philosophy 24 (1):47-59.
Jordan J. Cohen (2002). Managing Financial Conflicts of Interest in Clinical Research. Science and Engineering Ethics 8 (3):401-406.
Laurence J. Hirsch (2002). Conflicts of Interest in Drug Development: The Practices of Merck & Co., Inc. Science and Engineering Ethics 8 (3):429-442.
A. Górski (2001). Conflict of Interest and its Significance in Science and Medicine: A View From Eastern Europe. Science and Engineering Ethics 7 (3):307-312.
Sharmon Sollitto, Sharona Hoffman, Maxwell J. Mehlman, Robert J. Lederman, Stuart J. Youngner & Michael M. Lederman (2003). Intrinsic Conflicts of Interest in Clinical Research: A Need for Disclosure. Kennedy Institute of Ethics Journal 13 (2):83-91.
Sorry, there are not enough data points to plot this chart.
Added to index2009-01-28
Recent downloads (6 months)0
How can I increase my downloads?